Merck KGaA · Darmstadt Germany (German: MRK)
Key Merck KGaA Financials
| Company Type | Public -(German: MRK) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $12,311.9 |
| 2010 Employees | 40,562 |
Merck KGaA Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 12,311.9 | 11,103.0 | 10,653.0 |
| Cost of Goods Sold | 3,161.1 | 2,908.4 | 2,686.5 |
| Gross Profit | 9,150.8 | 8,194.6 | 7,966.5 |
| Gross Profit Margin | 74.3% | 73.8% | 74.8% |
| SG&A Expense | 3,594.9 | 3,865.6 | 3,584.1 |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | 1,470.2 | 889.9 | 1,030.9 |
| Operating Margin | 11.9% | 8% | 9.7% |
| Nonoperating Income | 4.4 | 0.0 | 0.0 |
| Nonoperating Expenses | (333.4) | (192.8) | (220.6) |
| Income Before Taxes | 1,141.1 | 697.1 | 810.3 |
| Income Taxes | 291.0 | 157.2 | 276.0 |
| Net Income After Taxes | 850.1 | 539.9 | 534.3 |
| Continuing Operations | 850.1 | 539.9 | 534.3 |
| Discontinued Operations | -- | -- | 0.0 |
| Total Operations | 850.1 | 539.9 | 534.3 |
| Total Net Income | 850.1 | 539.9 | 534.3 |
| Net Profit Margin | 6.9% | 4.9% | 5% |
| Diluted EPS from Total Net Income | 3.86 | 2.41 | 2.38 |
| Dividends per Share | 0.98 | 4.30 | -- |
All amounts in millions of US Dollars except per share amounts.
Merck KGaA Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 1,250.6 | 775.9 | 976.4 |
| Net Receivables | -- | -- | -- |
| Inventories | 2,217.7 | 1,960.5 | 1,983.7 |
| Other Current Assets | 4,037.9 | 5,192.2 | 3,183.5 |
| Total Current Assets | 7,506.2 | 7,928.6 | 6,143.6 |
| Net Fixed Assets | 4,295.6 | 3,737.2 | 3,439.3 |
| Other Noncurrent Assets | 17,866.7 | 12,286.7 | 12,468.3 |
| Total Assets | 29,668.6 | 23,952.5 | 22,051.2 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 1,590.4 | 1,341.0 | 1,189.2 |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | 2,861.8 | 2,700.6 | 2,163.2 |
| Total Current Liabilities | 4,452.1 | 4,041.6 | 3,352.4 |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | 11,471.7 | 6,276.0 | 5,138.6 |
| Total Liabilities | 15,923.9 | 10,317.6 | 8,491.0 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 13,744.7 | 13,634.9 | 13,479.0 |
| Total Equity | 13,744.7 | 13,634.9 | 13,479.0 |
| Shares Outstanding (thou.) | 64,621.1 | 64,621.1 | 64,621.1 |
All amounts in millions of US Dollars except per share amounts.
Merck KGaA Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 2,362 | 1,965 | 1,443 |
| Net Investing Cash Flow | (5,145.0) | (3,096.7) | (115.2) |
| Net Financing Cash Flow | 3,362.7 | 913.2 | (939.7) |
| Net Change in Cash | 580.0 | (218.1) | 388.5 |
| Depreciation & Amortization | |||
| Capital Expenditures | (663.1) | (808.2) | (754.9) |
| Cash Dividends Paid | (114.1) | (150.2) | (299.5) |
All amounts in millions of US Dollars except per share amounts.